Cargando…
Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines
Pulmonary administration route has been extensively exploited for the treatment of local lung diseases such as asthma, chronic obstructive pulmonary diseases and respiratory infections, and systemic diseases such as diabetes. Most inhaled medicines could be cleared rapidly from the lungs and their t...
Autores principales: | Guo, Yi, Bera, Hriday, Shi, Changzhi, Zhang, Li, Cun, Dongmei, Yang, Mingshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424368/ https://www.ncbi.nlm.nih.gov/pubmed/34522598 http://dx.doi.org/10.1016/j.apsb.2021.05.015 |
Ejemplares similares
-
In Vitro and In Vivo Evaluation of Inhalable Ciprofloxacin Sustained Release Formulations
por: Shi, Changzhi, et al.
Publicado: (2023) -
In vitro - in vivo - in silico approach in the development of inhaled drug products: Nanocrystal-based formulations with budesonide as a model drug
por: Shi, Changzhi, et al.
Publicado: (2021) -
Cases Illustrative of the Efficacy of Various Medicines, Administered by Inhalation, in Pulmonary Consumption
Publicado: (1831) -
Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors()
por: Guo, Xiong, et al.
Publicado: (2019) -
Strategies for refinement of occupational inhalation exposure evaluation in the EPA TSCA risk evaluation process
por: Lynch, Heather N., et al.
Publicado: (2023)